Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of GBP 875.39 million. The enterprise value is 861.25 million.

Market Cap	875.39M
Enterprise Value	861.25M

Important Dates

The last earnings date was Thursday, April 3, 2025.

Earnings Date	Apr 3, 2025
Ex-Dividend Date	Apr 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.19M

Valuation Ratios

The trailing PE ratio is 44.52.

PE Ratio	44.52
Forward PE	n/a
PS Ratio	5.79
PB Ratio	2.95
P/TBV Ratio	11.96
P/FCF Ratio	43.00
P/OCF Ratio	32.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.89, with an EV/FCF ratio of 42.31.

EV / Earnings	43.80
EV / Sales	5.65
EV / EBITDA	22.89
EV / EBIT	33.08
EV / FCF	42.31

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.06.

Current Ratio	2.53
Quick Ratio	1.53
Debt / Equity	0.06
Debt / EBITDA	0.49
Debt / FCF	0.90
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.59% and return on invested capital (ROIC) is 5.09%.

Return on Equity (ROE)	6.59%
Return on Assets (ROA)	4.25%
Return on Invested Capital (ROIC)	5.09%
Return on Capital Employed (ROCE)	7.91%
Revenue Per Employee	243,099
Profits Per Employee	31,612
Employee Count	680
Asset Turnover	0.40
Inventory Turnover	1.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.34% in the last 52 weeks. The beta is 0.84, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-12.34%
50-Day Moving Average	107.57
200-Day Moving Average	154.17
Relative Strength Index (RSI)	77.35
Average Volume (20 Days)	726,967

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of GBP 151.21 million and earned 19.66 million in profits. Earnings per share was 0.25.

Revenue	151.21M
Gross Profit	94.69M
Operating Income	25.83M
Pretax Income	22.36M
Net Income	19.66M
EBITDA	34.93M
EBIT	25.83M
Earnings Per Share (EPS)	0.25

Full Income Statement

Balance Sheet

The company has 32.39 million in cash and 18.35 million in debt, giving a net cash position of 14.03 million.

Cash & Cash Equivalents	32.39M
Total Debt	18.35M
Net Cash	14.03M
Net Cash Per Share	n/a
Equity (Book Value)	296.56M
Book Value Per Share	3.70
Working Capital	56.21M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.83 million and capital expenditures -6.48 million, giving a free cash flow of 20.36 million.

Operating Cash Flow	26.83M
Capital Expenditures	-6.48M
Free Cash Flow	20.36M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.62%, with operating and profit margins of 17.08% and 13.00%.

Gross Margin	62.62%
Operating Margin	17.08%
Pretax Margin	14.79%
Profit Margin	13.00%
EBITDA Margin	23.10%
EBIT Margin	17.08%
FCF Margin	13.46%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.13
Dividend Yield	0.09%
Dividend Growth (YoY)	9.14%
Years of Dividend Growth	n/a
Payout Ratio	50.20%
Buyback Yield	-3.44%
Shareholder Yield	-3.35%
Earnings Yield	2.25%
FCF Yield	2.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 10.32.

Altman Z-Score	10.32
Piotroski F-Score	n/a